Fewer Americans saw doctors during "Great Recession"

NEW YORK (Reuters Health) – Americans made fewer trips to their doctors’ offices during the Great Recession than they did earlier in the decade, according to new research. “These are not dramatic drops, but in our healthcare system we’re used to our numbers going up… So just seeing a reverse in the trend is interesting,” said Karoline Mortensen, the study’s lead author from the University of Maryland in College Park. …

Teva questions safety of MS drug from rival Biogen

(Reuters) – Teva Pharmaceutical Industries Ltd, which makes the market-leading multiple sclerosis drug Copaxone, has filed a petition with the U.S. Food and Drug Administration that could, if granted, delay entry to the market of a rival drug developed by Biogen Idec Inc. Teva’s petition asks that the FDA not approve any new multiple sclerosis drug until its safety has been evaluated by a panel of outside advisors, and said it had uncovered “troubling information” on a publicly accessible website about the safety of Biogen’s drug, BG-12. …

Poor people participate in cancer trials less often

NEW YORK (Reuters Health) – Poor people are less likely to take part in clinical trials for new cancer drugs, which can make it harder to develop treatments, according to a new study. “Cancer clinical trials are how we move the field forward. As a result of patients not participating in clinical trials, it takes a lot longer and it’s much more expensive to develop new therapies,” said Dr. Dawn Hershman, who worked on the study. “In this study we found one factor that contributes to that is patient income,” Hershman, from Columbia University in New York, told Reuters Health. …

1 64 65 66 67 68 92